Table 3.

HealthRise screening and diagnosis outputs for programme sites in Brazil, India and South Africa

Data collection	Across HealthRise sites	Brazil		India		South africa
		Teófilo otoni	Vitória da conquista	Udaipur	Shimla	Pixley ka seme	uMgungun-dlovu
Hypertension
Individuals screened*	59 342	3129	2315	26 144	20 606	2366	4782
Individuals screened above threshold†	6439	871	626	835	2214	677	1216
Individuals screened and newly diagnosed	1464	190	233	264	555	93	129
Diabetes
Individuals screened*	56 642	5396	3609	17 994	21 482	3570	4591
Individuals screened above threshold‡	2563	125	499	839	900	71	129
Individuals screened and newly diagnosed	295	40	44	107	56	24	24

*Individuals with no previously reported diagnosis of hypertension or diabetes and participated in a HealthRise-supported screening activity.

†SBP ≥140 mm Hg or DBP ≥90 mm Hg.

‡Random blood glucose (RBG) measure of ≥140 mg/dL in Vitória da Conquista and both India sites; fasting glucose (FG) ≥126 mg/dL or blood glucose of 200 mg/dL following a glucose tolerance test in both South Africa sites; and a RBG reading of ≥200 mg/dL with at least one classical diabetes symptom (polyuria, polydipsia or polyphagia) or a FG ≥126 mg/dL following a cardiovascular risk assessment (patients with a body mass index ≥25; or age ≥45, or at least moderate cardiovascular disease risk were referred to get a FG test at the health facility) in Teófilo Otoni.

DBP, diastolic blood pressure; SBP, systolic blood pressure.